Clinical Trial Update: A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trial update for a novel nutraceutical targeting Post-Lyme Disease Syndrome, now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-lyme Disease Syndrome

Drugs mentioned

• A Novel Nutraceutical (unspecified)

Snippet

Sponsor: Optimal Health Research | Conditions: Post-Lyme Disease Syndrome (PLDS) | Phase 2, Phase 3 | Status: COMPLETED